Antibiotic Pressure and Resistance in Bacteria Sarmistha B. Hauger M.D. Director, Pediatric Infectious Disease Childrens Hospital of Austin Austin, Texas.

Slides:



Advertisements
Similar presentations
Hospital-acquired and community-acquired MRSA in hospitals
Advertisements

Surveillance of antimicrobial resistance Liselotte Högberg Swedish Institute for Infectious Disease Control
Methicillin resistant Staphylococcus aureus (MRSA) in the Nordic countries Petter Elstrøm Advisor Norwegian Institute of Public Health.
The Resistance Problem PRSP = Penicillin Resistant Strep. pneumoniae QRSP = Quinolone Resistant Strep. pneumoniae MRSA = Methicillin Resistant Staph.
Streptococcus pneumoniae Chapter 23. Streptococcus pneumoniae S. pneumoniae was isolated independently by Pasteur and Steinberg more than 100 years ago.
Hot Topics in Pediatric ID Robert J. Leggiadro, MD Chairman Department of Pediatrics Lincoln Medical Center Professor of Clinical Pediatrics Weill Medical.
Update on Antimicrobial Resistance Allison McGeer, MD, FRCPC Mount Sinai Hospital
Challenges in Antibacterial Drug Development Francis P. Tally M.D. Cubist Pharmaceuticals, Inc.
Antibiotic Resistance why do we care? Thursday 1/10/2008.
Pathogenic Bacteriology Introduction. What the class will cover: Clinically significant bacteria Morphological characteristics Biochemical characteristics.
Antibiotic Resistance in Bacteria. Antibiotic Resistant Bacteria Are: Bacteria that mutate and are able to resist the antibiotics that are meant to kill.
MRSA and VRE. MRSA  1974 – MRSA accounted for only 2% of total staph infections  1995 – MRSA accounted for 22% of total staph infections  2004 – MRSA.
Use of antibiotics. Antibiotic use Antimicrobials are the 2 nd most common drugs prescribed by office based physicians In USA1992: 110 million oral antimicrobial.
Indication for Otitis Media FDA Vaccine and Related Biologicals Advisory Committee Meeting May 21, 2002 Pneumococcal 7-Valent Conjugate Vaccine (Diphtheria.
WHO Collaborating Center for Surveillance of Antimicrobial Resistance Boston, USA Antimicrobial resistance – Biological basis and public health consequences.
Big Bad Bugs in the Dialysis Unit Douglas Shemin, MD Kidney Diseases and Hypertension Division, Rhode Island Hospital.
Standard and Expanded Precautions
BIO 411 – Medical Microbiology Chapter 9 Commensal and Pathogenic Microbial Flora.
Infection Control and the Bugs. Blanche Lenard RN, CIC Education Session Infection Control in Healthcare  Environmental Cleaning  Routes of Transmission.
Clindamycin induction test in treating patients infected with methicilin resistant Staphylococcus aureus Presented by Iyad Kaddora.
CHOICE OF ANTIBIOTICS IN THE VIEW OF DEVELOPING ANTIBIOTIC RESISTANCE Dr. Jolanta Miciulevičienė Vilnius City Clinical Hospital National Public Health.
Hans Wolf-Watz, professor, UCMR, MIMS, Department of Microbiology, Umeå University, Sweden, Antibiotic resistance a new.
Biological Hazards Disease in Developed and Developing Countries.
MDR Organisms in Holy Family Hospital Rawalpindi
Methods Revised Abstract Methods Results TP-271 is a Potent, Broad-Spectrum Fluorocycline with Activity Against Community-Acquired Bacterial Respiratory.
Connie Cavenaugh UAMS’ Infection Control Practitioner
A new antivirulence approach against pathogenic bacteria A new antivirulence approach against pathogenic bacteria May 2005 Sonia Escaich - President &
Journal of the Pediatric Infectious Diseases Society Advance Access published June 2, 2014.
ANTIMICROBIAL RESISTANCE
Recommendation on prudent use of antimicrobial agents in human medicine – Slovenian experiences Intersectoral Coordination Mechanism Prof. Milan Čižman,
Designs to determine the impact of Ab resistance How do we correctly measure the outcomes of antibiotic resistance?
Microbiology- a clinical approach by Anthony Strelkauskas et al Chapter 20: Antibiotic resistance.
 At the end of the lecture, students should :  Describe briefly common types of meningitis  Describe the principles of treatment  List the name of.
SPM 100 Clinical Skills Lab 1 Standard Precautions Sterile Technique Daryl P. Lofaso, M.Ed, RRT.
Central Nervous System Infections. RABIES.
Streptococcus pneumoniae Lecture 9 Summer, 2004 Demosthenes Pappagianis, MD MMI 480B.
ROLE OF HAND HYGIENE IN PREVENTING TRANSMISSION OF INFECTIOUS DISEASES David Jay Weber, M.D., M.P.H. Medical Director, Hospital Epidemiology Professor.
ECDC-EMEA Joint Technical Report Part I: Trends and burden of antimicrobial resistance in the European Union Zsuzsanna Jakab, Director European Centre.
Bacterial Pneumonia.
Swedres 2005 Swedres 2005 Figures and tables. Swedres 2005 Table Total use of antibacterial drugs for systemic use in Sveden , DDD/1000/day.
SPM 100 Skills Lab 1 Standard Precautions Sterile Technique Daryl P. Lofaso, M.Ed, RRT Clinical Skills Lab Coordinator.
Antibiotics Broad Spectrum vs Narrow Spectrum. Two Groups of antibiotics An antibiotic may be classified basically as "narrow- spectrum" or "broad-spectrum"
Acute Otitis Media To treat or not to treat Gary Kroukamp.
MEDICATIONS FOR INFECTION Principles of Antiseptic, Disinfectant, & Antimicrobial Therapy ADN 110/cohort 13 1.
EARS-Net data on Antimicrobial Resistance in Ireland, Q3 2015
INTRODUCTION TO INFECTION CONTROL ICNO Infection Control Unit, Teaching Hospital, Jaffna.
European Centre for Disease Prevention and Control
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
MICROBIOLOGICAL EPIDEMIOLOGY OF RESPIRATORY SPECIMENS IN ICU PATIENTS Dr Farooq Cheema, Dr Waseem Tariq, Dr Raja Ishtiaq, Dr Tabassum Qureshi, Dr Vincent.
Laboratory Diagnosis Chapter 8. APPROACH TO LABORATORY DIAGNOSIS ● The laboratory diagnosis of infectious diseases involves two main approaches, the bacteriologic.
IMPORTANT ANTIBIOTICS AND ANTIMICROBIAL RESISTANCE A Presentation By Ms R.Venkatajothi, MSc., MPhil, PhD Senior Lecturer Department of Microbiology Faculty.
Kiran Ghimire, Baral B., Karna S., Baral M.P. PhD
Antibiotic-resistant Bacteria
Antibiotics: handle with care!
Use of antibiotics.
Antibiotics and Antibiotic Resistance
Antibiotics: handle with care!
ECDC-EMEA Joint Technical Report Part I: Trends and burden of antimicrobial resistance in the European Union Zsuzsanna Jakab, Director European Centre.
Summary of WHO PPL, CDC, and ESKAPE pathogen lists
A new antivirulence approach against pathogenic bacteria
Antimicrobial Resistance: from Global to Local
Neonatal sepsis in Kilifi
Non-antibiotic strategies for sepsis
Summary of WHO PPL, CDC, and ESKAPE pathogen lists
Healthcare Epidemiology Department
Multicenter study of the in vitro activity of cefepime in comparison with five other broad- spectrum antibiotics against clinical isolates of Gram-positive.
Current Threats to Public Health
Antibiotics: handle with care!
Presentation transcript:

Antibiotic Pressure and Resistance in Bacteria Sarmistha B. Hauger M.D. Director, Pediatric Infectious Disease Childrens Hospital of Austin Austin, Texas TDH CA-MRSA Conference September, 2004

Antibiotic Pressure and Resistance in Bacteria What is it and why is it important? How extensive is it? How does it happen? What factors promote the spread of resistant bacteria ? How does it pertain to the development of CA-MRSA infections? What can HCW do to curb this trend?

Antibiotic Pressure and Resistance in Bacteria What is it ? Selection pressure of antibiotics has led to the emergence of antibiotic-resistant bacteria. –Antibiotics can effect bacteria unrelated to the targeted infectious agent; these may be normal flora, leading to the emergence of resistant mutants inhabiting the same environment. Baquero et al., International Report 1996;23:819

Antibiotic Pressure and Resistance in Bacteria Why is it important? Antibiotic resistance has developed in almost all classes of bacteria of pathogenic potential. Resistance in organisms of low virulence can emerge as important pathogens. The development of resistant bacteria has driven pharmaceutical research to develop more potent, broad-spectrum antibiotics. Use of these in turn, has fueled the appearance of bacteria with newer modes of resistance.

Antibiotic Pressure and Resistance in Bacteria Why is it important? Infections with resistant bacteria occur in health care settings AND the community. Examples of hospital setting: MDR Gram neg, MRSA, VRE Examples of community : MRSA, PRSP, Pcn R Quin R N. gonorrhea, antibiotic resistant Salmonella and Shigella

Emergence of Antibiotic-Resistant Bacteria Cohen; Science 1992;257:1050 Gram-negative rods Enterococcus sp. N. gonorrhoeae H. influenzae M. catarrhalis S. pneumoniae S aureus PenicillinPenicillin AmpicillinAmpicillin 3 rd gen Cephalosporins Quinolones

Percentage of Laboratory Isolates Resistant to Antibiotics, Texas Percentage How extensive is the problem ?

Scope of Problem: S. pneumoniae Most common cause of bactemia, bacterial pneumonia, meningitis, OM, sinusitis in childhood. Highest rates of invasive pneumococcal disease occur among young children, especially those aged <2 years US data: the seven most common serotypes isolated from the blood or CSF of children age <6 years account for 80% of disease Antimicrobial resistance is detected most frequently among these same serotypes surveillance data from eight states: these serotypes accounted for 80% of penicillin-nonsusceptible isolates.

Percentage of Invasive Pneumococcal Isolates Nonsusceptible to Penicillin, Selected States,1997 Percentage CDC, MMWR 1999; 48(30):

Mechanisms of Bacterial Resistance : how DO they do it ??

Antibiotic Pressure and Resistance in Bacteria How does it occur? All antibiotics do NOT kill bacteria in the same way. Various classes of antibiotics work on different aspects of bacterial replication.

Folic acid synthesis ß -lactams & Glycopeptides ( Vancomycin) DNA mRNA Ribosomes PABA DHFA THFA Cell wall synthesis DNA gyrase Quinolones Protein synthesis inhibition Tetracyclines Protein synthesis mistranslation Macrolides & Lincomycins Cohen. Science 1992; 257:1064 DNA-directed RNA polymerase Rifampin Aminoglycosides Sulfonamides Trimethoprim

Antibiotic Pressure and Resistance in Bacteria How does it happen ? Bacteria can become resistant as a result of genetic mutations; these can be transferred between bacteria and groups of bacteria. Under selective pressure of antibiotic exposure, these strains then proliferate.

Antibiotic Pressure and Resistance in Bacteria What happened to S. aureus ? Can become Resistant to the B-lactam drugs (PCNs, Cephalosporins) by making a B- lactamase. In response to development of a drug that is stable to this mechanism (methicillin/oxacillin), S. aureus alters its binding site (PBP): Methicillin Resistant S. aureus (MRSA) In response to use of other types of antibx to combat MRSA: few strains now with decr. sens to vancomycin, clindamycin.

Antibiotic Pressure and Resistance in Bacteria What happened to S. aureus ? Reports of increasing use of third gen cephalosporins and quinolones related to emergence of MRSA. Some data suggest that quinolones enhance expression of methicillin reistance in SA in vitro Outbreaks of MRSA have been reduced by curbing antibiotic use: esp cephalosporins

Antibiotic Pressure and Resistance in Bacteria What factors promote their development and spread ? < Alteration of normal flora < Practices contributing to misuse of antibiotics < Settings that foster drug resistance < Failure to follow infection control principles

< Inappropriate specimen selection and collection < Inappropriate clinical tests < Failure to use stains/smears < Failure to use cultures and susceptibility tests Practices Contributing to Misuse of Antibiotics

< Inappropriate specimen selection and collection < Inappropriate clinical tests < Failure to use stains/smears < Failure to use cultures and susceptibility tests Practices Contributing to Misuse of Antibiotics

< Use of antibiotics with no clinical indication (eg, for viral infections) < Use of broad spectrum antibiotics when not indicated < Inappropriate choice of empiric antibiotics Inappropriate Antibiotic Use

< Inappropriate dose - ineffective concentration of antibiotics at site of infection < Inappropriate route - ineffective concentration of antibiotics at site of infection < Inappropriate duration Inappropriate Drug Regimen

Settings that Foster Drug Resistance < Day-care centers < Long term care facilities < Homeless shelters < Jails Community

Hospital < Intensive care units < Oncology units < Dialysis units < Rehab units < Transplant units < Burn units Settings that Foster Drug Resistance

Physicians Can Impact Other clinicians Patients Optimize patient evaluation Adopt judicious antibiotic prescribing practices Immunize patients Optimize consultations with other clinicians Use infection control measures Educate others about judicious use of antibiotics

Public campaign, physician education, and increased antibiotic cost Stephenson, JAMA 1996;275:175 Controlling Pneumococcal Resistance- Iceland % nonsusceptible S. pneumoniae

Controlling Erythromycin Resistance in Group A Streptococci - Finland Seppala, NEJM 1997;337:441 Year

Antibiotic Pressure and Resistance in Bacteria: Conclusions Bacteria evolve resistance to antibiotics in response to environmental pressure exerted by the use of antibiotics. Many of these bacteria are significant pathogens. Our responsibility to our community is to use antibiotics prudently, for appropriate indications.